Gilead Sciences, Inc. (GILD)
123.40
+2.06
(+1.70%)
USD |
NASDAQ |
Dec 11, 15:18
Gilead Sciences Market Cap: 153.10B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 169.99B |
| Johnson & Johnson | 504.02B |
| Eli Lilly & Co. | 901.10B |
| Merck & Co., Inc. | 245.00B |
| Pfizer Inc. | 146.09B |
Market Cap Related Metrics
| PE Ratio | 19.11 |
| PS Ratio | 5.338 |
| PEG Ratio | 0.0026 |
| Price to Book Value | 7.108 |
| Price to Free Cash Flow | 16.93 |
| Price | 123.40 |
| Earnings Yield | 5.23% |
| PEGY Ratio | 0.0026 |
| Operating PE Ratio | 13.68 |
| Normalized PE Ratio | 17.85 |